Various types of ROS were determined in untreated and drug-treated hematopoietic malignant cells by flow cytometry using live-cell permeant specific fluorogenic probes. Dihydroethidium (DHE, Marker Gene Technologies, M1241) was used as probe for detection of the cytosolic superoxide anion (cO2•-), MitoSox (Molecular Probes, M36008) was used as probe for detection of the mitochondrial superoxide anion (mO2•-) and 6-carboxy-2,7-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA; Molecular Probes, C-400) was used as probe for detection of H2O2. DHE was oxidized to red fluorescent ethidium by cytosolic superoxide and MitoSox was selectively targeted to mitochondria, where it was oxidized by superoxide and exhibited red fluorescence. Carboxy-H2DCFDA was cleaved by esterase to yield DCFH, a polar nonfluorescent product, but in the presence of hydrogen peroxide, the latter is oxidized to a green fluorescent product, dichlorofluorescent (DCF). For cell staining, cells were centrifuged and the pellets were resuspended in PBS with a final concentration of 5 μM for each probe. The mixture was incubated in the dark at 37 °C for 15 min. Then, the cell suspension was analyzed using flow cytometry within 20 min.
Free full text: Click here